Author:
Liu Chong,Wang Ye,Zhang Duo,Zhou Jin,Wu Yan,Guo Ying,Liu Rui-Chao,Xu Jin-E
Abstract
Abstract
Background
The study aimed to evaluate the diagnostic efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI) parameters in distinguishing sinonasal lymphoma from sinonasal carcinoma.
Methods
Forty-two participants with histologically confirmed sinonasal lymphomas and fifty-two cases of sinonasal carcinoma underwent imaging with a 3.0T MRI scanner. DCE-MRI and DWI were conducted, and various parameters including type of time-intensity curve(TIC), time to peak, peak enhancement, peak contrast enhancement, washout rate, apparent diffusion coefficient (ADC), and relative ADC were measured. Binary logistic regression and receiver operating characteristic (ROC) curve analysis were employed to assess the diagnostic capability of individual and combined indices for differentiating nasal sinus lymphoma from nasal sinus carcinoma.
Results
Sinonasal lymphoma predominantly exhibited type II TIC(n = 20), whereas sinonasal carcinoma predominantly exhibited type III TIC(n = 23). Significant differences were observed in all parameters except washout ratio (p < 0.05), and ADC value emerged as the most reliable diagnostic tool in single parameter. Combined DCE-MRI parameters demonstrated superior diagnostic efficacy compared to individual parameters, with the highest efficiency (area under curve = 0.945) achieved when combining all parameters of DCE-MRI and DWI.
Conclusions
Multiparametric evaluation involving contrast-enhanced dynamic MRI and DWI holds considerable diagnostic value in distinguishing sinonasal lymphoma from sinonasal carcinoma.
Funder
Baoding Science and Technology Bureau self-funded project
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Kumari S, Pandey S, Verma M, et al. Clinicopathological challenges in tumors of the Nasal Cavity and paranasal sinuses: our experience. Cureus. 2022;14(9):e29128.
2. Dutta R, Dubal PM, Svider PF, et al. Sinonasal malignancies: a population-based analysis of site-specific incidence and survival. Laryngoscope. 2015;125(11):2491–7.
3. Binazzi A, Corfiati M, Di Marzio D, et al. Sinonasal cancer in the Italian national surveillance system: epidemiology, occupation, and public health implications. Am J Ind Med. 2018;61(3):239–50.
4. Bracigliano A, Tatangelo F, Perri F, et al. Malignant sinonasal tumors: update on histological and clinical management. Curr Oncol. 2021;28(4):2420–38.
5. Storck K, Brandstetter M, Keller U, et al. Clinical presentation and characteristics of lymphoma in the head and neck region. Head Face Med. 2019;15:1–8.